SecBot SecBot
SECBOTREPLAY Home › Report › CTNM

CTNM · Three top insiders (CEO, CSO, and CMO) at Contineum Therapeutics…

Contineum Therapeutics, Inc. · CLUSTER filed Jul 2, 2026 at 17:47 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Jul 2, 2026 at 17:47 ET

Three top insiders (CEO, CSO, and CMO) at Contineum Therapeutics exercised and sold shares in a coordinated cluster totaling ~$796K in open-market sales on June 30, 2026. The cluster is entirely sell-side with a clear pattern of derivative exercises paired with immediate share sales, indicating a liquidity/vesting-driven event rather than a uniform bearish conviction call. At ~0.14% of the $570M market cap, the total is modest and within routine proportionality, despite the C-suite breadth.

  • Three insiders sold 37,186 shares in open-market sales on June 30- July 1, 2026, totaling ~$796K.
  • CEO Carmine Stengone sold 10,000 shares ($160K); CSO Daniel Lorrain sold 28,826 shares ($462K); CMO Tim Watkins sold 10,833 shares ($174K).
  • Each insider exercised stock options (prices $0-$4.50) immediately prior to or concurrent with the sales, a typical vesting-and-sell pattern.
  • Total open-market sales represent ~0.14% of the company's $570M market cap, below the 0.5% threshold for a notable cluster.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access